يعرض 1,561 - 1,580 نتائج من 13,108 نتيجة بحث عن '(( significant increase decrease ) OR ( significant ((threat decrease) OR (larger decrease)) ))', وقت الاستعلام: 0.46s تنقيح النتائج
  1. 1561
  2. 1562
  3. 1563
  4. 1564
  5. 1565

    Data Sheet 2_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf حسب Mi-Ae Lyu (20413646)

    منشور في 2025
    "…The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …"
  6. 1566

    Data Sheet 3_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf حسب Mi-Ae Lyu (20413646)

    منشور في 2025
    "…The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …"
  7. 1567

    Data Sheet 1_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf حسب Mi-Ae Lyu (20413646)

    منشور في 2025
    "…The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …"
  8. 1568
  9. 1569
  10. 1570
  11. 1571
  12. 1572
  13. 1573
  14. 1574
  15. 1575
  16. 1576
  17. 1577
  18. 1578

    Simulation platform experimental data. حسب Qingsong Zhang (3353270)

    منشور في 2024
    الموضوعات:
  19. 1579
  20. 1580

    Numerical simulation data. حسب Qingsong Zhang (3353270)

    منشور في 2024
    الموضوعات: